| __timestamp | TG Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 152381 | 580415000 |
| Thursday, January 1, 2015 | 152381 | 1032336000 |
| Friday, January 1, 2016 | 152381 | 1702177000 |
| Sunday, January 1, 2017 | 152381 | 2488652000 |
| Monday, January 1, 2018 | 152000 | 3047597000 |
| Tuesday, January 1, 2019 | 152000 | 4162821000 |
| Wednesday, January 1, 2020 | 152000 | 6205683000 |
| Friday, January 1, 2021 | 6689000 | 7574400000 |
| Saturday, January 1, 2022 | 2785000 | 8930700000 |
| Sunday, January 1, 2023 | 233662000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Vertex Pharmaceuticals Incorporated has demonstrated a remarkable upward trajectory, with revenues soaring from approximately $580 million in 2014 to nearly $9.9 billion in 2023. This represents an impressive growth rate of over 1,600%, underscoring Vertex's dominance in the biotech sector.
Conversely, TG Therapeutics, Inc. has experienced a more volatile revenue journey. From a modest $152,000 in 2014, TG Therapeutics saw a significant spike in 2023, reaching approximately $234 million. This surge, while substantial, highlights the challenges and opportunities faced by smaller biotech firms in scaling their operations.
This comparative analysis offers a fascinating glimpse into the contrasting paths of two biotech companies, each navigating the complexities of innovation and market demand in their unique ways.
Breaking Down Revenue Trends: Johnson & Johnson vs TG Therapeutics, Inc.
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs Vertex Pharmaceuticals Incorporated
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or Takeda Pharmaceutical Company Limited?
Revenue Insights: Vertex Pharmaceuticals Incorporated and BeiGene, Ltd. Performance Compared
Vertex Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Galapagos NV
Revenue Showdown: Vertex Pharmaceuticals Incorporated vs MiMedx Group, Inc.
Who Generates More Revenue? Zoetis Inc. or TG Therapeutics, Inc.
Revenue Insights: United Therapeutics Corporation and TG Therapeutics, Inc. Performance Compared
Revenue Showdown: TG Therapeutics, Inc. vs PTC Therapeutics, Inc.
Annual Revenue Comparison: TG Therapeutics, Inc. vs Geron Corporation
Comparing Revenue Performance: TG Therapeutics, Inc. or Viridian Therapeutics, Inc.?